In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good office that the Board of Directors of the Company, Medicamen Biotech Limited, at their meeting held today i.e February 13, 2024 at 05.00 PM has, inter alia, considered and approved the allotment of 63,500 Equity Shares of face value of Rs. 10/- each pursuant to conversion of 63,500 Fully Convertible Warrants ("Warrants") issued as on September 12, 2022, at an issue price of Rs. 709/- each, by way of preferential allotment.